Enfusion

Enfusion Equity Ratio

Delisted

The Equity Ratio of Enfusion (ENFN) as of Nov 7, 2026 is 51.11 %. In the previous year, Equity Ratio was 49.25 % — a change of 3.78% (higher).

Equity Ratio

51.11 %

YoY

3.78%

Last updated:

Equity Ratio of Enfusion is 2024 51.11 % . Equity Ratio of Enfusion was 2023 49.25 % . It decreases by 3.78% higher compared to the previous year.

The Enfusion Equity Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Ratio
Date
Equity Ratio
Jan 1, 2019
-508.16 USD
Jan 1, 2020
-597.35 USD
Jan 1, 2021
52.12 USD
Jan 1, 2022
52.52 USD
Jan 1, 2023
49.25 USD
Jan 1, 2024
51.11 USD
The Enfusion Equity Ratio history
YEAREquity RatioYoY
51.11 %+3.78%
49.25 %-6.23%
52.52 %+0.76%
52.12 %-108.73%
-597.35 %+17.55%
-508.16 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enfusion Stock analysis

What does Enfusion do? Enfusion Inc. generates revenue through cloud-native multi-tenant software solutions tailored for alternative and institutional investment managers. Its core products include the Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System, and Enfusion Analytics System, which collectively enable real-time investment decision-making. The company serves investment managers who require integrated systems for the full investment lifecycle, with PMS constructing and rebalancing portfolios while generating a real-time investment book of record, and OEMS facilitating electronic trade order communication for portfolio managers, traders, compliance teams, and analysts. The company's solution integrates technology-powered managed services to drive insights and control over investment operations. Enfusion's end-to-end functionality supports the entire investment process, from portfolio construction to trade execution, with PMS and OEMS operating in tandem to provide a seamless workflow. Investment managers across alternative and institutional segments purchase these integrated systems to enhance operational efficiency and decision-making capabilities. Enfusion's software is designed to serve the full investment lifecycle, with its systems integrated to provide a unified platform for portfolio management, order execution, accounting, and analytics. The company's revenue model is based on delivering these comprehensive solutions to investment managers who rely on real-time data and integrated workflows to manage their operations effectively. Enfusion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enfusion stock

Equity Ratio of Enfusion is 51.11 % in 2024.

Equity Ratio of Enfusion changed from 49.25 % to 51.11 %, representing a 3.78% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Equity Ratio Enfusion since 2006 – with annual values, charts, and detailed analysis.

The equity ratio measures the proportion of total assets financed by shareholders' equity. Higher ratios indicate stronger financial independence and lower leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Ratio's Enfusion with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Enfusion

All Key Metrics — Enfusion